$16.05
0.43%
Nasdaq, Sep 12, 10:00 pm CET

Sotera Health Co Target price 2025 - Analyst rating & recommendation

Sotera Health Co Classifications & Recommendation:

Buy
64%
Hold
36%

Sotera Health Co Price Target

Target Price $17.34
Price $16.05
Potential
Number of Estimates 7
7 Analysts have issued a price target Sotera Health Co 2026 . The average Sotera Health Co target price is $17.34. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 7 Analysts recommend Sotera Health Co to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sotera Health Co stock has an average upside potential 2026 of . Most analysts recommend the Sotera Health Co stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 1.10 1.17
4.87% 6.23%
EBITDA Margin 32.68% 49.52%
0.72% 51.51%
Net Margin 4.03% 19.29%
17.25% 378.74%

9 Analysts have issued a sales forecast Sotera Health Co 2025 . The average Sotera Health Co sales estimate is

$1.2b
Unlock
. This is
3.95% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.2b 8.49%
Unlock
, the lowest is
$1.1b 0.40%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.1b 4.87%
2025
$1.2b 6.23%
Unlock
2026
$1.2b 5.99%
Unlock
2027
$1.3b 6.13%
Unlock
2028
$1.4b 7.83%
Unlock

9 Analysts have issued an Sotera Health Co EBITDA forecast 2025. The average Sotera Health Co EBITDA estimate is

$579m
Unlock
. This is
57.04% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$609m 65.26%
Unlock
, the lowest is
$557m 51.00%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $360m 5.63%
2025
$579m 60.96%
Unlock
2026
$617m 6.53%
Unlock
2027
$657m 6.57%
Unlock
2028
$728m 10.79%
Unlock

EBITDA Margin

2024 32.68% 0.72%
2025
49.52% 51.51%
Unlock
2026
49.78% 0.53%
Unlock
2027
49.98% 0.40%
Unlock

9 Sotera Health Co Analysts have issued a net profit forecast 2025. The average Sotera Health Co net profit estimate is

$226m
Unlock
. This is
839.36% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$238m 892.50%
Unlock
, the lowest is
$217m 804.33%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $44.3m 13.21%
2025
$226m 408.66%
Unlock
2026
$254m 12.63%
Unlock
2027
$282m 10.88%
Unlock
2028
$333m 18.15%
Unlock

Net Margin

2024 4.03% 17.25%
2025
19.29% 378.74%
Unlock
2026
20.50% 6.27%
Unlock
2027
21.42% 4.49%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.16 0.79
11.11% 393.75%
P/E 20.21
EV/Sales 5.60

9 Analysts have issued a Sotera Health Co forecast for earnings per share. The average Sotera Health Co EPS is

$0.79
Unlock
. This is
887.50% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.84 950.00%
Unlock
, the lowest is
$0.76 850.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.16 11.11%
2025
$0.79 393.75%
Unlock
2026
$0.89 12.66%
Unlock
2027
$0.99 11.24%
Unlock
2028
$1.17 18.18%
Unlock

P/E ratio

Current 200.63 105.11%
2025
20.21 89.93%
Unlock
2026
17.95 11.18%
Unlock
2027
16.19 9.81%
Unlock
2028
13.70 15.38%
Unlock

Based on analysts' sales estimates for 2025, the Sotera Health Co stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.82 20.50%
2025
5.60 3.84%
Unlock
2026
5.28 5.65%
Unlock
2027
4.98 5.78%
Unlock

P/S ratio

Current 4.05 23.15%
2025
3.90 3.80%
Unlock
2026
3.68 5.65%
Unlock
2027
3.47 5.78%
Unlock

Current Sotera Health Co Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Barclays
Locked
Locked
Locked Jun 24 2025
Goldman Sachs
Locked
Locked
Locked May 05 2025
Piper Sandler
Locked
Locked
Locked Apr 23 2025
Barclays
Locked
Locked
Locked Apr 10 2025
Barclays
Locked
Locked
Locked Feb 28 2025
Barclays
Locked
Locked
Locked Feb 18 2025
RBC Capital
Locked
Locked
Locked Nov 21 2024
Analyst Rating Date
Locked
Barclays:
Locked
Locked
Jun 24 2025
Locked
Goldman Sachs:
Locked
Locked
May 05 2025
Locked
Piper Sandler:
Locked
Locked
Apr 23 2025
Locked
Barclays:
Locked
Locked
Apr 10 2025
Locked
Barclays:
Locked
Locked
Feb 28 2025
Locked
Barclays:
Locked
Locked
Feb 18 2025
Locked
RBC Capital:
Locked
Locked
Nov 21 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today